181 related articles for article (PubMed ID: 33568713)
1. The potential role of MR based radiomic biomarkers in the characterization of focal testicular lesions.
Feliciani G; Mellini L; Carnevale A; Sarnelli A; Menghi E; Piccinini F; Scarpi E; Loi E; Galeotti R; Giganti M; Parenti GC
Sci Rep; 2021 Feb; 11(1):3456. PubMed ID: 33568713
[TBL] [Abstract][Full Text] [Related]
2. An annotated T2-weighted magnetic resonance image collection of testicular germ and non-germ cell tumors.
Feliciani G; Mellini L; Loi E; Piccinini F; Galeotti R; Sarnelli A; Parenti GC
Sci Data; 2021 Aug; 8(1):209. PubMed ID: 34354085
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of testicular seminoma and nonseminomatous germ cell tumor on magnetic resonance imaging.
Liu R; Lei Z; Li A; Jiang Y; Ji J
Medicine (Baltimore); 2019 Nov; 98(45):e17937. PubMed ID: 31702681
[TBL] [Abstract][Full Text] [Related]
4. Clinical and radiographic characterization of primary seminomas and nonseminomatous germ cell tumors.
Gu L; Zhang L; Hou N; Li M; Shen W; Xie X; Teng Y
Niger J Clin Pract; 2019 Mar; 22(3):342-349. PubMed ID: 30837421
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of testicular seminomas from nonseminomas based on multiphase CT radiomics combined with machine learning: A multicenter study.
Fang F; Wu L; Luo X; Bu H; Huang Y; Xian Wu Y; Lu Z; Li T; Yang G; Zhao Y; Weng H; Zhao J; Ma C; Li C
Eur J Radiol; 2024 Jun; 175():111416. PubMed ID: 38460443
[TBL] [Abstract][Full Text] [Related]
6. Testicular tumors: discriminative value of conventional MRI and diffusion weighted imaging.
Wang W; Sun Z; Chen Y; Zhao F; Yu H; Guo X; Shi K
Medicine (Baltimore); 2021 Dec; 100(48):e27799. PubMed ID: 35049179
[TBL] [Abstract][Full Text] [Related]
7. MRI in the histologic characterization of testicular neoplasms.
Tsili AC; Tsampoulas C; Giannakopoulos X; Stefanou D; Alamanos Y; Sofikitis N; Efremidis SC
AJR Am J Roentgenol; 2007 Dec; 189(6):W331-7. PubMed ID: 18029845
[TBL] [Abstract][Full Text] [Related]
8. [Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].
Müller-Mattheis V; Reinhardt M; Gerharz CD; Fürst G; Vosberg H; Müller-Gärtner HW; Ackermann R
Urologe A; 1998 Nov; 37(6):609-20. PubMed ID: 9887489
[TBL] [Abstract][Full Text] [Related]
9. T2-Weighted Image-Based Radiomics Signature for Discriminating Between Seminomas and Nonseminoma.
Zhang P; Feng Z; Cai W; You H; Fan C; Lv W; Min X; Wang L
Front Oncol; 2019; 9():1330. PubMed ID: 31850216
[No Abstract] [Full Text] [Related]
10. Apparent diffusion coefficient values and dynamic contrast enhancement patterns in differentiating seminomas from nonseminomatous testicular neoplasms.
Tsili AC; Sylakos A; Ntorkou A; Stavrou S; Astrakas LG; Sofikitis N; Argyropoulou MI
Eur J Radiol; 2015 Jul; 84(7):1219-26. PubMed ID: 25937261
[TBL] [Abstract][Full Text] [Related]
11. Imaging Techniques to Differentiate Benign Testicular Masses from Germ Cell Tumors.
Saidian A; Bagrodia A
Curr Urol Rep; 2023 Sep; 24(9):451-454. PubMed ID: 37368095
[TBL] [Abstract][Full Text] [Related]
12. Characterization of testicular germ cell tumors: Whole-lesion histogram analysis of the apparent diffusion coefficient at 3T.
Min X; Feng Z; Wang L; Cai J; Yan X; Li B; Ke Z; Zhang P; You H
Eur J Radiol; 2018 Jan; 98():25-31. PubMed ID: 29279166
[TBL] [Abstract][Full Text] [Related]
13. Testicular Germ Cell Tumors: Classification, Pathologic Features, Imaging Findings, and Management.
Katabathina VS; Vargas-Zapata D; Monge RA; Nazarullah A; Ganeshan D; Tammisetti V; Prasad SR
Radiographics; 2021 Oct; 41(6):1698-1716. PubMed ID: 34597218
[TBL] [Abstract][Full Text] [Related]
14. Molecular Imaging for Evaluation of Viable Testicular Cancer Nodal Metastases.
Joice GA; Rowe SP; Gorin MA; Pierorazio PM
Curr Urol Rep; 2018 Nov; 19(12):110. PubMed ID: 30413968
[TBL] [Abstract][Full Text] [Related]
15. m
Lobo J; Costa AL; Cantante M; Guimarães R; Lopes P; Antunes L; Braga I; Oliveira J; Pelizzola M; Henrique R; Jerónimo C
J Transl Med; 2019 Mar; 17(1):79. PubMed ID: 30866959
[TBL] [Abstract][Full Text] [Related]
16. Contemporary options and future perspectives: three examples highlighting the challenges in testicular cancer imaging.
Wakileh GA; Ruf C; Heidenreich A; Dieckmann KP; Lisson C; Prasad V; Bolenz C; Zengerling F
World J Urol; 2022 Feb; 40(2):307-315. PubMed ID: 34779884
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted magnetic resonance imaging in the characterization of testicular germ cell neoplasms: Effect of ROI methods on apparent diffusion coefficient values and interobserver variability.
Tsili AC; Ntorkou A; Astrakas L; Xydis V; Tsampalas S; Sofikitis N; Argyropoulou MI
Eur J Radiol; 2017 Apr; 89():1-6. PubMed ID: 28267523
[TBL] [Abstract][Full Text] [Related]
18. [Observation policy for residual masses after chemotherapy for gonadal and extra-gonadal germ cell tumors].
Takizawa A; Miura T; Fujinami K; Osada Y
Hinyokika Kiyo; 2005 Apr; 51(4):247-51. PubMed ID: 15912783
[TBL] [Abstract][Full Text] [Related]
19. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
20. Significance of 18F-FDG PET/CT in Characterization of Equivocal Lesions in High-Risk Testicular Carcinoma in Restaging Setting.
Rasheed R; Al-Kandari F; Ghanem M; Marafi F; Usmani S
Asian Pac J Cancer Prev; 2020 Feb; 21(2):511-515. PubMed ID: 32102532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
